The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2

Chen, Liang, Li, Xiangjie, Chen, Mingquan, Feng, Yi, Xiong, Chenglong·2020·Cardiovascular Research
DOI 10.1093/cvr/cvaa078

Cited by (999)

Items 201–300 of 999

  1. Underlying Chronic Disease and COVID-19 Infection: A State-of-the-Art Review
    Habib Haybar, Khalil Kazemnia, Fakher Rahim · 2020 · Jundishapur Journal of Chronic Disease Care
  2. ACE2 in the renin–angiotensin system
    Thiago Verano‐Braga, Ana Luiza Valle Martins, Daisy Motta‐Santos, Maria José Campagnole‐Santos, Robson A.S. Santos · 2020 · Clinical Science
  3. Endothelialitis plays a central role in the pathophysiology of severe COVID-19 and its cardiovascular complications
    Christiaan J. Vrints, Konstantin Alexander Krychtiuk, Emeline M. Van Craenenbroeck, Vincent F. M. Segers, Susanna Price, Hein Heidbüchel · 2020 · Acta cardiologica. Supplementum
  4. European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1—epidemiology, pathophysiology, and diagnosis
    The Task Force for the management of COVID-19 of the European Society of Cardiology, Colin Baigent, Stephan Windecker, Daniele Andreini, Elena Arbelo, Emanuele Barbato, Antonio Luca Bartorelli, Andreas Baumbach, Elijah Raphael Behr, Sérgio Luis Berti et al. · 2021 · Cardiovascular Research
  5. Multiorgan MRI findings after hospitalisation with COVID-19 in the UK (C-MORE): a prospective, multicentre, observational cohort study
    Betty Raman, Celeste McCracken, Mark Philip Cassar, Alastair James Moss, Lucy Finnigan, Azlan Helmy Abd Samat, Godwin Inalegwu Ogbole, Elizabeth M. Tunnicliffe, Fidel Alfaro‐Almagro, Ricarda Menke et al. · 2023 · The Lancet Respiratory Medicine
  6. Pulmonary Vascular Pathology in Covid-19
    Felix Scholkmann, John Malcolm Nicholls · 2020 · New England Journal of Medicine
  7. COVID-19 and cardiovascular diseases
    Fan Liu, Feng Liu, Lu Wang · 2020 · Journal of Molecular Cell Biology
  8. SARS-CoV-2-Related Myocarditis-Like Syndromes Shakespeare’s Question: What’s in a Name?
    Sophie Van Linthout, Karin Klingel, Carsten Tschöpe · 2020 · European Journal of Heart Failure
  9. Good or bad: Application of RAAS inhibitors in COVID-19 patients with cardiovascular comorbidities
    James Jiqi Wang, Matthew L. Edin, Darryl C. Zeldin, Chenze Li, Dao Wen Wang, Chen Chen · 2020 · Pharmacology & Therapeutics
  10. Critical complications of COVID-19: A descriptive meta-analysis study
    Kimia Ghazi Vakili, Mobina Fathi, Fatemeh Sayehmiri, Ashraf Mohamadkhani, Mohammadreza Hajiesmaeili, Mostafa Rezaei–Tavirani, Aiyoub Pezeshgi · 2020 · Reviews in Cardiovascular Medicine
  11. Role of angiotensin-converting enzyme 2 and pericytes in cardiac complications of COVID-19 infection
    Fulton A. Robinson, Ryan P Mihealsick, Brant M. Wagener, Peter Hanna, Megan D. Poston, Igor R. Efimov, Kalyanam Shivkumar, Donald B. Hoover · 2020 · American Journal of Physiology-Heart and Circulatory Physiology
  12. Altered gut microbial metabolites could mediate the effects of risk factors in Covid‐19
    Jiezhong Chen, Sean Hall, Luis Vitetta · 2021 · Reviews in Medical Virology
  13. Retinal capillary involvement in early post-COVID-19 patients: a healthy controlled study
    Maria Cristina Savastano, Gloria Gambini, Grazia Maria Cozzupoli, Emanuele Crincoli, Alfonso Savastano, Umberto De Vico, Carola Culiersi, Benedetto Falsini, Francesco Martelli, Angelo Maria Minnella et al. · 2021 · Graefe s Archive for Clinical and Experimental Ophthalmology
  14. Myocardial Pathology in COVID-19-Associated Cardiac Injury: A Systematic Review
    Aniello Maiese, Paola Frati, Fabio Del Duca, Paola Santoro, Alice Chiara Manetti, Raffaele La Russa, Marco Di Paolo, Emanuela Turillazzi, Vittorio Fineschi · 2021 · Diagnostics
  15. Prevalence of Atrial Fibrillation and Associated Mortality Among Hospitalized Patients With COVID-19: A Systematic Review and Meta-Analysis
    Zuwei Li, Wen Shao, Jing Zhang, Jianyong Ma, Shanshan Huang, Peng Yu, Wengen Zhu, Xiao Liu · 2021 · Frontiers in Cardiovascular Medicine
  16. Clinical features of thrombosis and bleeding in COVID-19
    Mari R. Thomas, Marie Scully · 2022 · Blood
  17. Progress in cardiac research: from rebooting cardiac regeneration to a complete cell atlas of the heart
    Sean M. Davidson, Teresa Padró, Sveva Bollini, Gemma Vilahur, Dirk Jan Duncker, Paul Charles Evans, Tomasz Jan Guzik, Imo E. Hoefer, Johannes L. Waltenberger, Johann Wojta et al. · 2021 · Cardiovascular Research
  18. Novel Evidence of Acute Kidney Injury in COVID-19
    Ti-I Chueh, Cai‐Mei Zheng, Yi‐Chou Hou, Kuo‐Cheng Lu · 2020 · Journal of Clinical Medicine
  19. Dynamic Regulation of SARS-Cov-2 Binding and Cell Entry Mechanisms in Remodeled Human Ventricular Myocardium
    Michael R. Bristow, Lawrence S. Zisman, Natasha Lipson Altman, Edward Michael Gilbert, Brian D. Lowes, Wayne A. Minobe, Dobromir B. Slavov, Jessica A. Schwisow, Erin M. Rodriguez, Ian A. Carroll et al. · 2020 · JACC Basic to Translational Science
  20. COVID-19 as a viral functional ACE2 deficiency disorder with ACE2 related multi-organ disease
    Rosemary Gan, Nicholas Rosoman, David J.E. Henshaw, Euan P Noble, Peter Georgius, Nigel Sommerfeld · 2020 · Medical Hypotheses
  21. Cardiac injury is associated with severe outcome and death in patients with Coronavirus disease 2019 (COVID-19) infection: A systematic review and meta-analysis of observational studies
    Mohammad Parohan, Sajad Yaghoubi, Asal Seraji · 2020 · European Heart Journal Acute Cardiovascular Care
  22. COVID-19-associated liver injury: from bedside to bench
    Dongxiao Li, Xiangming Ding, Meng Xie, Dean Tian, Limin Xia · 2021 · Journal of Gastroenterology
  23. Corticosteroids for COVID-19: worth it or not?
    Fariya Akter, Yusha Araf, Mohammad Jakir Hosen · 2021 · Molecular Biology Reports
  24. Increased complications of COVID-19 in people with cardiovascular disease: Role of the renin–angiotensin-aldosterone system (RAAS) dysregulation
    Robin Augustine, Abhilash S, Ajisha Nayeem, Shaheen Abdul Salam, Priya Augustine, Pan Dan, Pablo Maureira, Fatima Mraiche, Carmine Gentile, Philip M. Hansbro et al. · 2021 · Chemico-Biological Interactions
  25. The Impact of Angiotensin-Converting Enzyme 2 (ACE2) Expression Levels in Patients with Comorbidities on COVID-19 Severity: A Comprehensive Review
    Rui Rodrigues, Sofia Costa‐de‐Oliveira · 2021 · Microorganisms
  26. Recent Insight into SARS-CoV2 Immunopathology and Rationale for Potential Treatment and Preventive Strategies in COVID-19
    Sara Lega, Samuele Naviglio, Stefano Volpi, Alberto Tommasini · 2020 · Vaccines
  27. COVID-19 associated thrombotic thrombocytopenic purpura (TTP) ; A case series and mini-review
    Hamed Azhdari Tehrani, Maryam Darnahal, Mohammad Vaezi, Shirin Haghighi · 2021 · International Immunopharmacology
  28. Mechanisms of SARS‐CoV‐2‐induced lung vascular disease: potential role of complement
    Kurt R. Stenmark, Maria G. Frid, Evgenia V. Gerasimovskaya, Hui Zhang, Mary K. McCarthy, Joshua M. Thurman, Thomas E. Morrison · 2021 · Pulmonary Circulation
  29. ACE2 polymorphisms as potential players in COVID-19 outcome
    André Salim Khayat, Paulo Pimentel de Assumpção, Bruna Cláudia Meireles Khayat, Taíssa Maíra Thomaz Araújo, Jéssica Almeida Batista-Gomes, Luciana Carvalho Imbiriba, Geraldo Ishak, P. P. ASSUMPÇÃO, Fabiano Cordeiro Moreira, Rommel Mário Rodríguez Burbano et al. · 2020 · PLoS ONE
  30. Clinical Characteristics and Mechanisms of Acute Myocarditis
    Stephane R B Heymans, Sophie Van Linthout, Sarah Kraus, Leslie T. Cooper, Ntobeko Ntusi · 2024 · Circulation Research
  31. Potential of SARS-CoV-2 to Cause CNS Infection: Biologic Fundamental and Clinical Experience
    Jianhan Huang, Meijun Zheng, Xin Tang, Yaxing Chen, Aiping Tong, Liangxue Zhou · 2020 · Frontiers in Neurology
  32. Incidence and impact of cardiac arrhythmias in coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis
    Raymond Pranata, Ian Huang, Sunu Budhi Raharjo · 2020 · Indian Pacing and Electrophysiology Journal
  33. Identification of biomarkers and pathways for the SARS-CoV-2 infections that make complexities in pulmonary arterial hypertension patients
    Tasnimul Alam Taz, Kawsar Ahmed, Bikash Kumar Paul, Fahad Ahmed Al-Zahrani, Saifuddin Mahmud, Mohammad Ali Moni · 2021 · Briefings in Bioinformatics
  34. Interaction of SARS-CoV-2 with cardiomyocytes: Insight into the underlying molecular mechanisms of cardiac injury and pharmacotherapy
    Abdi, Abdulhamid, AlOtaiby, Shahad, Badarin, Firas Al, Khraibi, Ali, Hamdan, Hamdan, Nader, Moni · 2022 · Biomedicine & Pharmacotherapy
  35. Myocardial and Microvascular Injury Due to Coronavirus Disease 2019
    Rocco Antonio Montone, Giulia Iannaccone, Maria Chiara Meucci, Filippo Luca Gurgoglione, Giampaolo Niccoli · 2020 · European Cardiology Review
  36. Cardiorenal Tissues Express SARS-CoV-2 Entry Genes and Basigin (BSG/CD147) Increases With Age in Endothelial Cells
    Blerina Ahmetaj‐Shala, Ricky Vaja, Santosh S. Atanur, Peter Myles George, Nicholas S. Kirkby, Jane A. Mitchell · 2020 · JACC Basic to Translational Science
  37. Cardiovascular Complications of COVID-19: Pharmacotherapy Perspective
    Azita H. Talasaz, Hessam Kakavand, Benjamin W. Van Tassell, Maryam Aghakouchakzadeh, Parham Sadeghipour, Steven P. Dunn, Babak Geraiely · 2020 · Cardiovascular Drugs and Therapy
  38. Innate Immune Cells and Hypertension: Neutrophils and Neutrophil Extracellular Traps (NETs)
    Cameron Grant McCarthy, Piu Saha, Rachel M. Golonka, Camilla Ferreira Wenceslau, Bina Joe, Matam Vijay–Kumar · 2021 · Comprehensive physiology
  39. Mechanisms of COVID-19 pathogenesis in diabetes
    Chandrakala Aluganti Narasimhulu, Dinender Kumar Singla · 2022 · American Journal of Physiology-Heart and Circulatory Physiology
  40. COVID‐19 and renin‐angiotensin system inhibition: role of angiotensin converting enzyme 2 (ACE2) ‐ Is there any scientific evidence for controversy?
    Aneta Aleksova, Federico Ferro, Giulia Gagno, Chiara Cappelletto, Daniela Santon, Maddalena Rossi, Giuseppe Ippolito, Alimuddin I. Zumla, Antonio Paolo Beltrami, Gianfranco Sinagra · 2020 · Journal of Internal Medicine
  41. Role for Anti-Cytokine Therapies in Severe Coronavirus Disease 2019
    Leo Francis Buckley, George F. Wohlford, Clara Ting, Abdullah A. Alahmed, Benjamin W. Van Tassell, Antonio Abbate, John W. Devlin, Peter Libby · 2020 · Critical Care Explorations
  42. Association between cardiac troponin I and mortality in patients with COVID-19
    Michela Salvatici, Barbara Barbieri, Sara Cioffi, Emanuela Morenghi, Francesco Paolo Leone, Federica Maura, Giuseppe Moriello, Maria Teresa Sandri · 2020 · Biomarkers
  43. Long COVID-19 and the Heart: Is Cardiac Mitochondria the Missing Link?
    Xing Chang, Nur Izzah Ismail, Attaur Rahman, Dachun Xu, Renee W. Y. Chan, Sang‐Ging Ong, Sang‐Bing Ong · 2022 · Antioxidants and Redox Signaling
  44. Targeting inflammatory cytokine storm to fight against COVID-19 associated severe complications
    Rishabh Hirawat, Mohd Aslam Saifi, Chandraiah Godugu · 2020 · Life Sciences
  45. Angiotensin-converting enzyme 2 and COVID-19: patients, comorbidities, and therapies
    Girish Pathangey, Priyal Fadadu, Alexa R. Hospodar, Amr E. Abbas · 2020 · American Journal of Physiology-Lung Cellular and Molecular Physiology
  46. Cardiac tissue model of immune-induced dysfunction reveals the role of free mitochondrial DNA and the therapeutic effects of exosomes
    Rick Xing Ze Lu, Naimeh Rafatian, Yimu Zhao, Karl T. Wagner, Erika Leigh Beroncal, Bo Li, Carol M. Lee, Jingan Chen, Eryn Churcher, Daniel Vosoughi et al. · 2024 · Science Advances
  47. COVID-19 and the World with Co-Morbidities of Heart Disease, Hypertension and Diabetes
    Arumugam Vijaya Anand, Thangavelu Sangeetha, Zareena Fathah, Ravindran Pavithra, Ann Mary Alappat Sanjeev, Sunantha Babu, Arun Meyyazhagan, Mohd. Iqbal Yatoo, Khan Sharun, Ruchi Tiwari et al. · 2020 · Journal of Pure and Applied Microbiology
  48. Preferential uptake of SARS-CoV-2 by pericytes potentiates vascular damage and permeability in an organoid model of the microvasculature
    Abdullah Obaid Khan, Jasmeet Singh Reyat, Harriet J. Hill, Joshua H. Bourne, Martina Colicchia, Maddy L. Newby, Joel D. Allen, Max Crispin, Esther Youd, Paul Gerard Murray et al. · 2022 · Cardiovascular Research
  49. COVID-19 mRNA Vaccines: The Molecular Basis of Some Adverse Events
    Girolamo Giannotta, Antonio Murrone, Nicola Giannotta · 2023 · Vaccines
  50. COVID-19-related cardiac complications from clinical evidences to basic mechanisms: opinion paper of the ESC Working Group on Cellular Biology of the Heart
    Maurizio Pesce, Piergiuseppe Agostoni, Hans Erik Bøtker, Bianca J.J.M. Brundel, Sean M. Davidson, Raffaele De Caterina, Péter Ferdinandy, Henrique Girão, Mariann Gyöngyösi, Jean‐Sébastien Hulot et al. · 2021 · Cardiovascular Research
  51. Do Changes in ACE-2 Expression Affect SARS-CoV-2 Virulence and Related Complications: A Closer Look into Membrane-Bound and Soluble Forms
    Huseyin Cagatay Yalcin, Vijayakumar Sukumaran, Mahmoud Khatib A. A. Al-Ruweidi, Samar Shurbaji · 2021 · International Journal of Molecular Sciences
  52. A Review of Postmortem Findings in Patients With COVID-19
    Adenike O Eketunde, Sai Priyanka Mellacheruvu, Philip Oreoluwa · 2020 · Cureus
  53. Long-Term Outcomes in Acute Respiratory Distress Syndrome
    Jessica A. Palakshappa, Jennifer Krall, Lanazha T. Belfield, Daniel Clark Files · 2021 · Critical Care Clinics
  54. Coronary “Microvascular Dysfunction”: Evolving Understanding of Pathophysiology, Clinical Implications, and Potential Therapeutics
    Chun Yeung Kei, Kuljit Singh, Rustem F. Dautov, Thanh Ha Tuan Nguyen, Yuliy Y. Chirkov, John David Horowitz · 2023 · International Journal of Molecular Sciences
  55. Pathogenesis and Treatment Strategies of COVID-19-Related Hypercoagulant and Thrombotic Complications
    MA Haimei · 2020 · Clinical and Applied Thrombosis/Hemostasis
  56. SARS-CoV-2 receptor ACE2 expression in the human heart: cause of a post-pandemic wave of heart failure?
    Thomas Thum · 2020 · European Heart Journal
  57. COVID‐19 infection, progression, and vaccination: Focus on obesity and related metabolic disturbances
    Annemarie J. F. Westheim, Albert V. Bitorina, Jan Theys, Ronit Shiri‐Sverdlov · 2021 · Obesity Reviews
  58. COVID and the Renin-Angiotensin System: Are Hypertension or Its Treatments Deleterious?
    Florian Zorès, Mathieu Edouard Rebeaud · 2020 · Frontiers in Cardiovascular Medicine
  59. Understanding the heart-brain axis response in COVID-19 patients: A suggestive perspective for therapeutic development
    Vincenzo Lionetti, Sveva Bollini, Raffaele Coppini, Andrea Gerbino, Alessandra Ghigo, Guido Iaccarino, Rosalinda Madonna, Fabio Mangiacapra, Michele Miragoli, Francesco Domenico Moccia et al. · 2021 · Pharmacological Research
  60. Approaching coronavirus disease 2019: Mechanisms of action of repurposed drugs with potential activity against SARS-CoV-2
    Lucia Lisi, Pedro Miguel Lacal, Maria Luisa Barbaccia, Grazia Graziani · 2020 · Biochemical Pharmacology
  61. Mechanisms of COVID‐19‐induced cardiovascular disease: Is sepsis or exosome the missing link?
    Mallikarjun Patil, Sarojini Singh, John Henderson, Prasanna Krishnamurthy · 2020 · Journal of Cellular Physiology
  62. Cell Clearing Systems as Targets of Polyphenols in Viral Infections: Potential Implications for COVID-19 Pathogenesis
    Fiona Limanaqi, Carla Letizia Busceti, Francesca Biagioni, Gloria Lazzeri, Maurizio Forte, Sonia Schiavon, Sebastiano Sciarretta, Giacomo Frati, Francesco Fornai · 2020 · Antioxidants
  63. The Role of MSC Therapy in Attenuating the Damaging Effects of the Cytokine Storm Induced by COVID-19 on the Heart and Cardiovascular System
    Georgina M. Ellison, Liam Sean Colley, Katie A. O’Brien, Kirsty A. Roberts, Thomas A. Agbaedeng, Mark Ross · 2020 · Frontiers in Cardiovascular Medicine
  64. Heart–lung interactions in COVID-19: prognostic impact and usefulness of bedside echocardiography for monitoring of the right ventricle involvement
    Michael Dandel · 2021 · Heart Failure Reviews
  65. Can COVID 2019 induce a specific cardiovascular damage or it exacerbates pre-existing cardiovascular diseases?
    Gelsomina Mansueto, Massimo Niola, Claudio Napoli A · 2020 · Pathology - Research and Practice
  66. SARS-CoV-2, ACE2, and Hydroxychloroquine: Cardiovascular Complications, Therapeutics, and Clinical Readouts in the Current Settings
    Rajkumar Singh Kalra, Dhanendra Tomar, Avtar S. Meena, Ramesh J. L. Kandimalla · 2020 · Pathogens
  67. Role of multimodality imaging in evaluation of cardiovascular involvement in COVID-19
    Rodolfo Citro, Gianluca Pontone, Michele Bellino, Angelo Silverio, Giuseppe Iuliano, Andrea Baggiano, Robert Manka, Severino Iesu, Carmine Vecchione, Federico M. Asch et al. · 2020 · Trends in Cardiovascular Medicine
  68. Early cardiac involvement in patients with acute COVID-19 infection identified by multiparametric cardiovascular magnetic resonance imaging
    Binghua Chen, Nan-Nan Shi, Chong‐Wen Wu, Dong‐Aolei An, Yuxin Shi, Luke David Wesemann, Jiani Hu, Jianrong Xu, Fei Shan, Lian‐Ming Wu · 2021 · European Heart Journal - Cardiovascular Imaging
  69. Single-cell technologies to decipher cardiovascular diseases
    Wesley Tyler Abplanalp, Nathan R. Tucker, Stefanie Dimmeler · 2022 · European Heart Journal
  70. Lung Pericytes in Pulmonary Vascular Physiology and Pathophysiology
    Ke Yuan, Stuti Agarwal, Ananya Chakraborty, David F. Condon, Hiral J. Patel, Serena Zhang, Flora Huang, Salvador A. Mello, Obadiah I. Kirk, Rocio Vasquez et al. · 2021 · Comprehensive physiology
  71. Pathogenesis of SARS-CoV-2 induced cardiac injury from the perspective of the virus
    Kirk U. Knowlton · 2020 · Journal of Molecular and Cellular Cardiology
  72. Systemic Inflammation May Induce Cardiac Injury in COVID-19 Patients Including Children and Adolescents Without Underlying Cardiovascular Diseases: A Systematic Review
    Arwa Saed Aldien, Gowrii Saswathy Ganesan, Farah Wahbeh, Noor Al‐Nassr, Heba N. Altarawneh, Lolwa Al Theyab, Summia Saed Aldien, Sara Tomerak, Hiba Naveed, Mohamed Badreldin Elshazly et al. · 2021 · Cardiovascular revascularization medicine
  73. Downregulation of ACE2 expression by SARS-CoV-2 worsens the prognosis of KIRC and KIRP patients via metabolism and immunoregulation
    Qian Tang, Yue Wang, Ling Ou, Jieling Li, Kai Zheng, Hui Zhan, Jiayu Gu, Guibao Zhou, Shouxia Xie, Jianping Zhang et al. · 2021 · International Journal of Biological Sciences
  74. Biomimetic lung-on-a-chip to model virus infection and drug evaluation
    Jianfeng Tan, Quanwei Guo, Lingling Tian, Zhendong Pei, Dongfang Li, Mengxi Wu, Jianhua Zhang, Xinghua Gao · 2022 · European Journal of Pharmaceutical Sciences
  75. Coronary heart disease and COVID-19: A meta-analysis
    Chendi Liang, Weijun Zhang, Shuzhen Li, Gang Qin · 2021 · Medicina Clínica (English Edition)
  76. Natural Products Modulating Angiotensin Converting Enzyme 2 (ACE2) as Potential COVID-19 Therapies
    Murtala Bello Abubakar, Dawoud Usman, Gaber El‐Saber Batiha, Natália Alves Martins, Ibrahim Malami, Kasimu Ghandi Ibrahim, Bilyaminu Abubakar, Muhammad Bashir Bello, Aliyu Idris Muhammad, Siew Hua Gan et al. · 2021 · Frontiers in Pharmacology
  77. Can Beta-2-Adrenergic Pathway Be a New Target to Combat SARS-CoV-2 Hyperinflammatory Syndrome?—Lessons Learned From Cancer
    Antônio Barbieri, Nirmal Robinson, Giuseppe Palma, Nicola Maurea, Vincenzo Desiderio, Gerardo Botti · 2020 · Frontiers in Immunology
  78. Impact of congestive heart failure and role of cardiac biomarkers in COVID-19 patients: A systematic review and meta-analysis
    Tarun Dalia, Shubham Lahan, Sagar Ranka, Prakash Acharya, Archana S. Gautam, Amandeep Goyal, Ioannis Mastoris, Andrew J. Sauer, Zubair I. Shah · 2020 · Indian Heart Journal
  79. The Role of Endothelium in COVID-19
    Mihaela Ionescu, Anca Pantea Stoian, Manfredi Rizzo, Dragoş Şerban, Domenico Nuzzo, Laura Mazilu, Andra‐Iulia Suceveanu, Ana Maria Dascălu, Irinel Raluca Parepa · 2021 · International Journal of Molecular Sciences
  80. Cell-Specific Mechanisms in the Heart of COVID-19 Patients
    Tsai, Emily J., Čiháková, Daniela, Tucker, Nathan R. · 2023 · Circulation Research
  81. A review of severe acute respiratory syndrome coronavirus 2 infection in the reproductive system
    Hsin-Hui Huang, Peng‐Hui Wang, Yi-Ping Yang, Shih‐Jie Chou, Po-Wei Chu, Gwo‐Jang Wu, Cheng‐Chang Chang · 2020 · Journal of the Chinese Medical Association
  82. Comparison of infection risks and clinical outcomes in patients with and without SARS‐CoV‐2 lung infection under renin–angiotensin–aldosterone system blockade: Systematic review and meta‐analysis
    Chang Chu, Shufei Zeng, Ahmed Abdallah Hasan, Carl‐Friedrich Hocher, Bernhard Karl Krämer, Berthold Hocher · 2020 · British Journal of Clinical Pharmacology
  83. Integration of cardiovascular risk assessment with COVID-19 using artificial intelligence
    Jasjit S. Suri, Anudeep Puvvula, Misha Majhail, Mainak Biswas, Ankush D. Jamthikar, Luca Saba, Gavino Faa, Inder M. Singh, Ronald Oberleitner, Monika Turk et al. · 2020 · Reviews in Cardiovascular Medicine
  84. Incidence, Characteristics and Outcomes of Large Vessel Stroke in COVID-19 Cohort: An International Multicenter Study
    Priyank Khandelwal, Fawaz Al‐Mufti, Ambooj Tiwari, Amit Singla, Adam Andrew Dmytriw, Mariangela Piano, Luca Quilici, Guglielmo Pero, Leonardo Renieri, Nicola Limbucci et al. · 2021 · Neurosurgery
  85. Characterisation of cardiac pathology in 23 autopsies of lethal COVID ‐19
    Jasmin D. Haslbauer, Alexandar Tzankov, Kirsten D. Mertz, Nathalie Schwab, Ronny Nienhold, Raphael Twerenbold, Gregor Leibundgut, Anna Katharina Stalder, Matthias Sebastian Matter, Katharina Glatz · 2021 · The Journal of Pathology Clinical Research
  86. The emerging role of perivascular cells (pericytes) in viral pathogenesis
    Teemapron Butsabong, Mariana Felippe, Paola Campagnolo, Kevin Maringer · 2021 · Journal of General Virology
  87. COVID-19 Is a Multi-Organ Aggressor: Epigenetic and Clinical Marks
    Mankgopo Kgatle, Ismaheel O. Lawal, Gabriel T. Mashabela, Tebatso M.G. Boshomane, Palesa Caroline Koatale, Phetole Walter Mahasha, Honest Ndlovu, Mariza Vorster, Hosana Gomes Rodrigues, Jan Rijn Zeevaart et al. · 2021 · Frontiers in Immunology
  88. SARS-CoV-2 triggers pericyte-mediated cerebral capillary constriction
    Chanawee Hirunpattarasilp, Greg James, Jaturon Kwanthongdee, Felipe Freitas, Jiandong Huo, Huma Sethi, Josef T. Kittler, Raymond J. Owens, Laura E. McCoy, David Attwell · 2022 · Brain
  89. Single-cell RNA sequencing to identify cellular heterogeneity and targets in cardiovascular diseases: from bench to bedside
    Xinjie Xu, Xiumeng Hua, Mo Han, Shengshou Hu, Jiangping Song · 2023 · Basic Research in Cardiology
  90. Pathogenic mechanisms of cardiovascular damage in COVID-19
    Honghua Shao, Rui‐Xing Yin · 2024 · Molecular Medicine
  91. The Chief Scientist Office Cardiovascular and Pulmonary Imaging in SARS Coronavirus disease-19 (CISCO-19) study
    Kenneth Mangion, Andrew Morrow, Catherine N. Bagot, Hannah Kelly Bayes, Kevin G. Blyth, Colin Church, David S. Corcoran, Christian Delles, Lynsey Gillespie, D Grieve et al. · 2020 · Cardiovascular Research
  92. Mesenchymal Stromal Cells in Viral Infections: Implications for COVID-19
    José Lucas Martins Rocha, Waldir César Ferreira de Oliveira, Nádia de Cássia Noronha, Natalia Cristine Dias dos Santos, Dimas Tadeu Covas, Virgínia Picanço‐Castro, Kamilla Swiech, Kelen Cristina Ribeiro Malmegrim · 2020 · Stem Cell Reviews and Reports
  93. From Influenza Virus to Novel Corona Virus (SARS-CoV-2)–The Contribution of Obesity
    Indranil Bhattacharya, Chafik Ghayor, Ana Pérez Domínguez, Franz E. Weber · 2020 · Frontiers in Endocrinology
  94. Angiotensin-converting enzyme 2 and COVID-19 in cardiorenal diseases
    Ravindra Kumar Sharma, Jing Li, Suraj Krishnan, Elaine M. Richards, Mohan K. Raizada, Rajesh Mohandas · 2021 · Clinical Science
  95. The Case Fatality Rate in COVID-19 Patients With Cardiovascular Disease: Global Health Challenge and Paradigm in the Current Pandemic
    Siddhartha Dan, Mohit Pant, Sushil Kumar Upadhyay · 2020 · Current Pharmacology Reports
  96. COVID-19 and vascular disorders (literature review)
    Н. Н. Петрищев, Olga Khalepo, Ю А Вавиленкова, Timur Dmitrievich Vlasov · 2020 · Regional blood circulation and microcirculation
  97. Higher ACE2 expression levels in epicardial cells than subcutaneous stromal cells from patients with cardiovascular disease: Diabetes and obesity as possible enhancer
    Marinela Couselo‐Seijas, Cristina Almengló, Rosa María Agra-Bermejo, Ángel Luis Fernández, Ezequiel Álvarez, José Ramón González‐Juanatey, Sonia Eiras-Penas · 2020 · European Journal of Clinical Investigation
  98. The effects of novel coronavirus (SARS-CoV-2) infection on cardiovascular diseases and cardiopulmonary injuries
    Li Ni, Linwen Zhu, Lebo Sun, Guofeng Shao · 2021 · Stem Cell Research
  99. The Novel Perspectives Opened by ST2 in the Pandemic: A Review of Its Role in the Diagnosis and Prognosis of Patients with Heart Failure and COVID-19
    Radu-Ştefan Miftode, Antoniu Octavian Petriş, Viviana Onofrei Aursulesei, Corina Maria Cianga, Irina Iuliana Costache, Ovidiu Mitu, Ionela-Larisa Miftode, Ionela-Lăcrămioara Șerban · 2021 · Diagnostics
  100. Acute Cardiac Injury in Coronavirus Disease 2019 and Other Viral Infections—A Systematic Review and Meta-Analysis
    Matthew Pellan Cheng, Alessandro Cau, Todd Campbell Lee, Daniel Brodie, Arthur S. Slutsky, John C. Marshall, Srinivas Murthy, Terry Lee, Joel Singer, Koray K. Demir et al. · 2021 · Critical Care Medicine